Bayer teams with Evotec on endometriosis
This article was originally published in Scrip
Executive Summary
Bayer and Evotec have signed a five-year collaboration to develop clinical candidates for endometriosis, a condition that Datamonitor Healthcare analysts view as offering the most attractive market for pharma companies in the women's health space.